1-MLCL(0:0/14:1(9Z)/15:1(9Z)/16:1(9Z)) (YMDB11547)

Identification
YMDB IDYMDB11547
Name1-MLCL(0:0/14:1(9Z)/15:1(9Z)/16:1(9Z))
SpeciesSaccharomyces cerevisiae
StrainBrewer's yeast
Description1-MLCL(0:0/14:1(9Z)/15:1(9Z)/16:1(9Z)) is a monolysocardiolipin (MLCL). Monolysocardiolipins have three fatty acid tails, instead of the usual two. 1-MLCL(0:0/14:1(9Z)/15:1(9Z)/16:1(9Z)) contains one chain of at the C1 position, one chain of (9Z-tetradecenoyl) at the C2 position, one chain of (9Z-pentadecenoyl) at the C3 position, one chain of (9Z-hexadecenoyl) at the C4 position. MLCL is present in eukaryotes as part of the metabolic cycle of mitochondrial lipids. Removal of one acyl chain from a cardiolipin results in generation of monolysocardiolipin (MLCL). MLCL has been used as an inter­mediate in the synthesis of spin-labeled CL to study the interaction of CL with mitochondrial enzymes. Because a role for MLCL has been suggested in apoptosis, this molecule has been used to study its interaction with various enzymes involved in lipid remodeling and apoptosis. There are two species of monolysocardiolipins, 1-MLCL which is missing a fatty acid in position R1 the and 2-MLCL which is missing a fatty acid in position R4.
Structure
Thumb
MOLSDFPDBSMILESInChI
SynonymsNot Available
CAS numberNot Available
WeightAverage: 1067.326
Monoisotopic: 1066.648661136
InChI KeyNHPHLSJCQKTXSB-RKTUUCHXSA-N
InChIInChI=1S/C54H100O16P2/c1-4-7-10-13-16-19-22-24-27-30-33-36-39-42-54(59)70-51(46-64-52(57)40-37-34-31-28-26-23-20-17-14-11-8-5-2)48-68-72(62,63)66-45-49(56)44-65-71(60,61)67-47-50(43-55)69-53(58)41-38-35-32-29-25-21-18-15-12-9-6-3/h15,17-20,22,49-51,55-56H,4-14,16,21,23-48H2,1-3H3,(H,60,61)(H,62,63)/b18-15-,20-17-,22-19-/t49-,50+,51+/m0/s1
IUPAC Name[(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(9Z)-pentadec-9-enoyloxy]propoxy][(2S)-2-hydroxy-3-({hydroxy[(2R)-3-hydroxy-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphoryl}oxy)propoxy]phosphinic acid
Traditional IUPAC Name(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(9Z)-pentadec-9-enoyloxy]propoxy((2S)-2-hydroxy-3-{[hydroxy((2R)-3-hydroxy-2-[(9Z)-tetradec-9-enoyloxy]propoxy)phosphoryl]oxy}propoxy)phosphinic acid
Chemical FormulaC54H100O16P2
SMILES[H][C@](O)(COP(O)(=O)OC[C@@]([H])(CO)OC(=O)CCCCCCC\C=C/CCCC)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCC\C=C/CCCCC)OC(=O)CCCCCCC\C=C/CCCCCC
Chemical Taxonomy
Physical Properties
StateSolid
Charge0
Melting pointNot Available
Experimental Properties
PropertyValueReference
Water SolubilityNot AvailablePhysProp
LogPNot AvailablePhysProp
Predicted Properties
PropertyValueSource
Water Solubility0.00038 g/LALOGPS
logP7.78ALOGPS
logP14.37ChemAxon
logS-6.4ALOGPS
pKa (Strongest Acidic)1.59ChemAxon
pKa (Strongest Basic)-3ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count9ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area230.88 ŲChemAxon
Rotatable Bond Count56ChemAxon
Refractivity286.06 m³·mol⁻¹ChemAxon
Polarizability121.06 ųChemAxon
Number of Rings0ChemAxon
Bioavailability0ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleYesChemAxon
Biological Properties
Cellular Locations
  • Mitochondrion membrane
Organoleptic PropertiesNot Available
SMPDB Pathways
Cardiolipin Biosynthesis CL(14:1(9Z)/15:1(9Z)/16:1(9Z)/23:1(11Z))PW010958 ThumbThumb?image type=greyscaleThumb?image type=simple
Cardiolipin Biosynthesis CL(14:1(9Z)/15:1(9Z)/16:1(9Z)/23:1(9Z))PW010959 ThumbThumb?image type=greyscaleThumb?image type=simple
Cardiolipin Biosynthesis CL(14:1(9Z)/15:1(9Z)/16:1(9Z)/25:0)PW010960 ThumbThumb?image type=greyscaleThumb?image type=simple
Cardiolipin Biosynthesis CL(14:1(9Z)/15:1(9Z)/16:1(9Z)/25:1(11Z))PW010961 ThumbThumb?image type=greyscaleThumb?image type=simple
Cardiolipin Biosynthesis CL(14:1(9Z)/15:1(9Z)/16:1(9Z)/25:1(9Z))PW010962 ThumbThumb?image type=greyscaleThumb?image type=simple
KEGG PathwaysNot Available
SMPDB Reactions
CL(14:1(9Z)/15:1(9Z)/16:1(9Z)/23:1(11Z)) → 1-MLCL(0:0/14:1(9Z)/15:1(9Z)/16:1(9Z))
CL(14:1(9Z)/15:1(9Z)/16:1(9Z)/23:1(9Z)) → 1-MLCL(0:0/14:1(9Z)/15:1(9Z)/16:1(9Z))
CL(14:1(9Z)/15:1(9Z)/16:1(9Z)/25:0) → 1-MLCL(0:0/14:1(9Z)/15:1(9Z)/16:1(9Z))
CL(14:1(9Z)/15:1(9Z)/16:1(9Z)/25:1(11Z)) → 1-MLCL(0:0/14:1(9Z)/15:1(9Z)/16:1(9Z))
CL(14:1(9Z)/15:1(9Z)/16:1(9Z)/25:1(9Z)) → 1-MLCL(0:0/14:1(9Z)/15:1(9Z)/16:1(9Z))
KEGG ReactionsNot Available
Concentrations
Intracellular ConcentrationsNot Available
Extracellular ConcentrationsNot Available
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-053b-5090122040-f0a94a831f025c64479fJSpectraViewer
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-06rb-4290122130-d1128de883578efb8156JSpectraViewer
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-053r-4290222000-d492699bd70d8982a2f2JSpectraViewer
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-0079-2090000020-ce1fa1f824f15caf6636JSpectraViewer
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-004i-8192021000-d6e91e1541326913b082JSpectraViewer
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-004i-9061001000-65deb0a0cc3bd81f1104JSpectraViewer
References
References:
  • Baile MG, Lu YW, Claypool SM. (2014). "The topology and regulation of cardiolipin biosynthesis and remodeling in yeast." Chem Phys Lipids. 2014 Apr;179:25-31. doi: 10.1016/j.chemphyslip.2013.10.008. Epub 2013 Nov 1.24184646
Synthesis Reference:Not Available
External Links:
ResourceLink
CHEBI IDNot Available
HMDB IDNot Available
Pubchem Compound IDNot Available
Kegg IDNot Available
ChemSpider IDNot Available
FOODB IDNot Available
Wikipedia IDNot Available
BioCyc IDNot Available